ID

22267

Description

A Study to Assess the Long-term Performance of SmartSet® HV and SmartSet® GHV Bone Cements in Primary Total Hip Replacement; ODM derived from: https://clinicaltrials.gov/show/NCT00872066

Lien

https://clinicaltrials.gov/show/NCT00872066

Mots-clés

  1. 28/05/2017 28/05/2017 -
Téléchargé le

28 mai 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Rheumatoid Arthritis NCT00872066

Eligibility Rheumatoid Arthritis NCT00872066

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
i) male or female subjects, aged between 18 and 75 years (inclusive).
Description

gender, age

Type de données

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
ii) subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
Description

informed consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
iii) subjects who, in the opinion of the investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.
Description

compliance

Type de données

boolean

Alias
UMLS CUI [1]
C1321605
iv) subjects requiring primary total hip arthroplasty and are considered suitable for a cemented femoral component.
Description

total hip arthroplasty with cemented femoral component

Type de données

boolean

Alias
UMLS CUI [1,1]
C0040508
UMLS CUI [1,2]
C0492265
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
i) subjects who, in the opinion of the investigator, have an existing condition that would compromise their participation and follow-up in this study.
Description

comorbidity

Type de données

boolean

Alias
UMLS CUI [1]
C0009488
ii) women who are pregnant.
Description

pregnancy

Type de données

boolean

Alias
UMLS CUI [1]
C0032961
iii) subjects who are known drug or alcohol abusers or with psychological disorders that could effect follow-up care or treatment outcomes.
Description

substance abuse, psychological disorders

Type de données

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2]
C0004936
iv) subjects who have participated in a clinical study with an investigational product in the last 6 month(s).
Description

study participation, investigational product

Type de données

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C3898691
v) subjects who are currently involved in any injury litigation claims.
Description

injury litigation claims

Type de données

boolean

Alias
UMLS CUI [1,1]
C3263723
UMLS CUI [1,2]
C0079706
UMLS CUI [1,3]
C0021677
vi) subjects with contraindications normally applicable to the use of conventional bone cement, in accordance with the manufacturer's instructions for use.
Description

bone cement contraindication

Type de données

boolean

Alias
UMLS CUI [1,1]
C0005934
UMLS CUI [1,2]
C0522473

Similar models

Eligibility Rheumatoid Arthritis NCT00872066

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
gender, age
Item
i) male or female subjects, aged between 18 and 75 years (inclusive).
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
informed consent
Item
ii) subjects who are able to give voluntary, written informed consent to participate in this investigation and from whom consent has been obtained.
boolean
C0021430 (UMLS CUI [1])
compliance
Item
iii) subjects who, in the opinion of the investigator, are able to understand this investigation, co-operate with the investigational procedures and are willing to return to the hospital for all the required post-operative follow-ups.
boolean
C1321605 (UMLS CUI [1])
total hip arthroplasty with cemented femoral component
Item
iv) subjects requiring primary total hip arthroplasty and are considered suitable for a cemented femoral component.
boolean
C0040508 (UMLS CUI [1,1])
C0492265 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
comorbidity
Item
i) subjects who, in the opinion of the investigator, have an existing condition that would compromise their participation and follow-up in this study.
boolean
C0009488 (UMLS CUI [1])
pregnancy
Item
ii) women who are pregnant.
boolean
C0032961 (UMLS CUI [1])
substance abuse, psychological disorders
Item
iii) subjects who are known drug or alcohol abusers or with psychological disorders that could effect follow-up care or treatment outcomes.
boolean
C0038586 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
study participation, investigational product
Item
iv) subjects who have participated in a clinical study with an investigational product in the last 6 month(s).
boolean
C2348568 (UMLS CUI [1,1])
C3898691 (UMLS CUI [1,2])
injury litigation claims
Item
v) subjects who are currently involved in any injury litigation claims.
boolean
C3263723 (UMLS CUI [1,1])
C0079706 (UMLS CUI [1,2])
C0021677 (UMLS CUI [1,3])
bone cement contraindication
Item
vi) subjects with contraindications normally applicable to the use of conventional bone cement, in accordance with the manufacturer's instructions for use.
boolean
C0005934 (UMLS CUI [1,1])
C0522473 (UMLS CUI [1,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial